French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins
Saturday, October 27th, 2007.
Cancer/Radiothérapie. 2007 Nov;11(6-7):331-337. Epub 2007 Oct 24. [Link]
Kantor G, Mahé MA, Giraud P; et les contributeurs des protocoles, Alapetite C, Durdux C, Fourquet A, Gardner M, Le Prisé E, Maire JP, Richaud P, Vendrely V, Caron J, Dejean C, Lisbona A, Munos C, Zefkili S, Mazal A.
Service de radiothérapie, institut Bergonié, 229, cours de l’Argonne, 33076 Bordeaux cedex, France.
Abstract
After a request for proposal initiated by National Institute against cancer (INCa) in 2005, three French centers in France started tomotherapy in the first semester of 2007. A national policy of evaluation was performed to study the feasibility of this innovative technique and to compare the interest of helicoidal tomotherapy with other modalities of conformal therapy. Common protocols have been designed to facilitate this evaluation. Description of dose, IMRT levels and constraints are achieved according to each selected indication as: sarcoma, head and neck tumors, lung cancer, mesothelioma, bone metastases, anal carcinoma and craniospinal irradiation.
Keywords: Helicoidal tomotherapy; Evaluation
